mash glp 1 Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual and triple agonists Incretin-based therapies in MASLD/MASH: from

Were already participating in this mostly through whole grain products and things like that

Fortunately, GLP-1-based therapeutics have recently become blockbuster drugs to treat obesity and diabetes, already benefiting hundreds of millions of users with great future prospects

Differentials to be considered Addison Disease Blue Nevi Ephelides (Freckles) Kaposi Sarcoma Oral Nevi Other Problems to be Considered: Amalgam tattoo Graphite tattoo Oral melanotic macule Peutz-Jeghers syndrome Physiologic pigmentation The amalgam tattoo is a frequent finding in persons who have had amalgam restorations (ie, fillings)

Key Takeaway: Feeling cold is often an indirect result of a caloric deficit and the loss of insulating body fat rather than a direct toxic reaction to the medication

The Research Profile section below details the mechanisms and the literature that frames each

Diabetes 1999